Omnicell Inc (OMCL) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally.
Total Assets Chart for Omnicell Inc
Omnicell Inc (OMCL) total assets for FY2025 were USD 2.0B, a -6.9% change from FY2024. Omnicell Inc's total assets grew from USD 43.9M in 2000 to USD 2.0B in 2025 (4397.7% over 25 years). Total assets compound annual growth rate: 5-year CAGR of 1.6%, 10-year CAGR of 13.1%, 20-year CAGR of 16.1%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $1.72B
- Implied Share Price
- $37.75
- Enterprise Value
- $1.41B
- Revenue (TTM)
- $1.25B
- EBITDA
- $82.18M
- Profit Margin
- 3.14%
- Trailing P/E
- 44.94
- Forward P/E
- 29.50
- Price/Book (MRQ)
- 1.17
- Price/Sales (TTM)
- 1.38
- EV/EBITDA
- 9.87
- EV/Revenue
- 1.13
- Dividend Yield
- —
- Book Value
- $28.32
- Free Cash Flow (FY2025)
- $86.89M
- Free Cash Flow Yield
- 5.06%
Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.